Nasdaq:US$18.72 (-0.96) | HKEX:HK$29.75 (-0.60) | AIM:£3.04 (-0.09)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 30 Nov 2010

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)